Effect of Rifampin on the Pharmacokinetics of Evacetrapib in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 09 Oct 2018
Price : $35 *
At a glance
- Drugs Evacetrapib (Primary) ; Rifampicin
- Indications Atherosclerosis; Cardiovascular disorders; Dyslipidaemias; Tuberculosis
- Focus Pharmacokinetics
- 01 Sep 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Aug 2013 New trial record
- 01 Jul 2013 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.